ENTPD1 and inflammatory bowel disease: In this review, we will discuss the role of the purinergic signaling, with a focus on P1 and P2 receptors and on ENTPD1/CD39 and CD73 ectoenzymes, in the context of inflammatory bowel disease (IBD).